These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 2874066)

  • 1. Periodic acid-Schiff stain as a prognostic indicator in serous and mucinous ovarian tumors.
    Aalto ML; Collan Y
    Int J Gynaecol Obstet; 1986 Feb; 24(1):27-34. PubMed ID: 2874066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosubstances in classification of serous and mucinous ovarian tumors: a morphometrical study.
    Aalto ML
    Eur J Obstet Gynecol Reprod Biol; 1986 Jul; 22(3):139-44. PubMed ID: 3732584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of carcinoembryonic antigen and periodic acid-Schiff stains in the diagnosis of serous and mucinous ovarian tumors: morphometrical study.
    Aalto ML; Selkäinaho K; Collan Y
    Appl Pathol; 1986; 4(1-2):83-9. PubMed ID: 3034311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients.
    Devaney K; Goodman ZD; Ishak KG
    Am J Surg Pathol; 1994 Nov; 18(11):1078-91. PubMed ID: 7943529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometry and AgNORs in benign, borderline, and malignant mucinous and serous tumours of the ovary.
    Griffiths AP; Cross D; Kingston RE; Harkin P; Wells M; Quirke P
    Int J Gynecol Pathol; 1993 Oct; 12(4):307-14. PubMed ID: 8253547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutral mucosubstances as a prognostic indicator in serous and endometrioid carcinomas of the ovary. A morphometrical analysis of saliva-periodic acid-Schiff stain.
    Aalto ML
    Int J Gynaecol Obstet; 1986 Dec; 24(6):453-7. PubMed ID: 20419910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferative serous tumors of the ovary. Histologic features and prognosis.
    Katzenstein AL; Mazur MT; Morgan TE; Kao MS
    Am J Surg Pathol; 1978 Dec; 2(4):339-55. PubMed ID: 736209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic neoplasms of the pancreas.
    Yamaguchi K; Enjoji M
    Gastroenterology; 1987 Jun; 92(6):1934-43. PubMed ID: 3471621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic cystadenoma and cystadenocarcinoma.
    von Segesser L; Rohner A
    Br J Surg; 1984 Jun; 71(6):449-51. PubMed ID: 6722483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDM2 Expression in Serous and Mucinous Epithelial Tumours of the Ovary.
    Abdelaal SE; Habib FM; El Din AA; Gabal SM; Hassan NS; Ibrahim NA
    Asian Pac J Cancer Prev; 2016; 17(7):3295-300. PubMed ID: 27509966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mucin histochemical and immunohistochemical studies of mucinous ovarian tumors].
    Shi ZL
    Zhonghua Bing Li Xue Za Zhi; 1989 Sep; 18(3):201-3. PubMed ID: 2636063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of glucose transporter protein 1 and p63 in serous ovarian tumor.
    Cai Y; Zhai JJ; Feng BB; Duan XZ; He XJ
    J Obstet Gynaecol Res; 2014 Jul; 40(7):1925-30. PubMed ID: 25056472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cystic pancreatic tumors].
    Schneider C; Reck T; Greskötter KR; Köckerling F; Gall FP
    Langenbecks Arch Chir; 1993; 378(5):281-7. PubMed ID: 8412436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine cells in cystic mucinous tumours of the ovary.
    Louwerens JK; Schaberg A; Bosman FT
    Histopathology; 1983 May; 7(3):389-98. PubMed ID: 6192070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudomyxoma peritonei. A clinicopathologic study of 19 cases with emphasis on site of origin and nature of associated ovarian tumors.
    Prayson RA; Hart WR; Petras RE
    Am J Surg Pathol; 1994 Jun; 18(6):591-603. PubMed ID: 8179074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic importance of the nucleolar organizer region score in ovarian epithelial tumors.
    Zergeroğlu S; Aksakal O; Demirtürk F; Gökmen O
    Gynecol Obstet Invest; 2001; 51(1):60-3. PubMed ID: 11150878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of papillary tubal hyperplasia (PTH), salpingoliths and transition from adenoma to borderline ovarian tumors (BOT): A systematic analysis of 74 BOT with different histologic types.
    Horn LC; Angermann K; Hentschel B; Einenkel J; Höhn AK
    Pathol Res Pract; 2017 Apr; 213(4):305-309. PubMed ID: 28238382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis.
    Rutgers JL; Scully RE
    Cancer; 1988 Jan; 61(2):340-8. PubMed ID: 3334969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucinous tumors of the vermiform appendix and ovary, and pseudomyxoma peritonei: histogenetic implications of cytokeratin 7 expression.
    Guerrieri C; Frånlund B; Fristedt S; Gillooley JF; Boeryd B
    Hum Pathol; 1997 Sep; 28(9):1039-45. PubMed ID: 9308728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of intraoperative frozen section for the evaluation of ovarian neoplasms: an institutional experience.
    Hashmi AA; Naz S; Edhi MM; Faridi N; Hussain SD; Mumtaz S; Khan M
    World J Surg Oncol; 2016 Mar; 14():91. PubMed ID: 27029917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.